In a breakthrough new development, Neuralink, a brain-computer interface company, has created a Blindsight implant capable of restoring vision for individuals who have lost both eyes, founder Elon Musk announced on Wednesday. 

The experimental device received the "breakthrough device" designation from the US Food and Drug Administration on Tuesday. 

Musk explained that initially, the restored vision would be of low resolution, similar to video game graphics. However, with further advancements, the technology could surpass natural vision, allowing people to see infrared, ultraviolet, and even radar wavelengths.

“The Blindsight device from Neuralink will enable even those who have lost both eyes and their optic nerve to see. Provided the visual cortex is intact, it will even enable those who have been blind from birth to see for the first time,” Musk said. 

Trials Expected To Conclude In Few Years

According to information from the US government's clinical trials database, the trial will include three patients and is expected to conclude in a few years.

The FDA's "breakthrough device" designation is granted to certain medical devices that have the potential to treat or diagnose life-threatening conditions. The innovative device has not yet entered human trials, and neither Neuralink nor the US FDA has provided a timeline for when that might begin. 

Meanwhile, Neuralink is also testing an implant designed to allow quadriplegic patients to operate digital devices using only their thoughts. This advanced technology could benefit individuals with spinal cord injuries.

Elon Musk founded Neuralink in 2016 alongside a team of seven experts in fields like neuroscience, biochemistry, and robotics. The company previously developed a groundbreaking chip capable of restoring full body control to individuals with paralysis. To date, two people have successfully received the brain-chip implant, following approval from the US FDA.